These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Diagnosis and treatment of Paget's disease of bone: a mini-review. Ferraz-de-Souza B, Correa PH. Arq Bras Endocrinol Metabol; 2013 Nov; 57(8):577-82. PubMed ID: 24343625 [Abstract] [Full Text] [Related]
23. Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid. Polyzos SA, Anastasilakis AD, Efstathiadou Z, Litsas I, Kita M, Panagiotou A, Papatheodorou A, Arsos G, Moralidis E, Barmpalios G, Zafeiriadou E, Triantafillidou E, Makrigiannaki E, Terpos E. J Bone Miner Metab; 2010 May; 28(3):314-9. PubMed ID: 19841860 [Abstract] [Full Text] [Related]
24. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment. Alvarez L, Peris P, Guañabens N, Vidal S, Quintó L, Monegal A, Pons F, Ballesta AM, Muñoz-Gómez J. Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158 [Abstract] [Full Text] [Related]
25. The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone. Polyzos SA, Anastasilakis AD, Efstathiadou Z, Kita M, Litsas I, Avramidis A, Arsos G, Moralidis E, Gerou S, Pavlidou V, Papatheodorou A, Terpos E. Horm Metab Res; 2009 Nov; 41(11):846-50. PubMed ID: 19670154 [Abstract] [Full Text] [Related]
26. [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience]. Conesa Mateos A, Rotés Sala D, Almirall Bernabé M, Carbonell Abelló J. Med Clin (Barc); 2006 Oct 28; 127(16):635-6. PubMed ID: 17145033 [No Abstract] [Full Text] [Related]
27. Long-Term Efficacy of Intensive Zoledronate Therapy and Predictors of Retreatment in Paget's Disease of Bone. Barale M, Sigrist S, Bioletto F, Maiorino F, Ghigo E, Mazzetti R, Procopio M. Calcif Tissue Int; 2021 Oct 28; 109(4):383-392. PubMed ID: 33876253 [Abstract] [Full Text] [Related]
28. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease? Krane SM. Nat Clin Pract Rheumatol; 2006 Apr 28; 2(4):186-7. PubMed ID: 16932682 [No Abstract] [Full Text] [Related]
30. Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone. Polyzos SA, Kountouras J, Anastasilakis AD, Litsas I, Kita M, Arsos G, Moralidis E, Terpos E. Osteoporos Int; 2011 Jan 28; 22(1):363-7. PubMed ID: 20407889 [Abstract] [Full Text] [Related]
33. (18)F-fluoride PET for monitoring therapeutic response in Paget's disease of bone. Installé J, Nzeusseu A, Bol A, Depresseux G, Devogelaer JP, Lonneux M. J Nucl Med; 2005 Oct 28; 46(10):1650-8. PubMed ID: 16204715 [Abstract] [Full Text] [Related]
34. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline. Muschitz C, Feichtinger X, Haschka J, Kocijan R. Wien Med Wochenschr; 2017 Feb 28; 167(1-2):18-24. PubMed ID: 27600563 [Abstract] [Full Text] [Related]
35. Proposed new approach for treating Paget's disease of bone. Mahmood W, McKenna MJ. Ir J Med Sci; 2011 Mar 28; 180(1):121-4. PubMed ID: 21132539 [Abstract] [Full Text] [Related]
39. Paget's disease of bone: analysis of 134 cases from an island in Southern Brazil: another cluster of Paget's disease of bone in South America. Werner de Castro GR, Heiden GI, Zimmermann AF, Morato EF, Neves FS, Toscano MA, de Magalhães Souza Fialho SC, Pereira IA. Rheumatol Int; 2012 Mar 28; 32(3):627-31. PubMed ID: 21127877 [Abstract] [Full Text] [Related]